Lily Zhao
Director, Scientific Advisor, CRO Service WuXi Biologics
Seminars
Wednesday 16th September 2026
Bispecific Antibody Discovery: Practical Strategies from MOA to Preclinical Candidates
4:15 pm
- Advanced antibody discovery platforms for biology-driven lead identification
- Comprehensive in vitro functional assays across T-cell engagers (TCEs), immune checkpoint inhibitors, and autoimmune diseases
- Extensive in vivo efficacy models and well-established PK/PD/Tox platforms delivering time- and cost-effective solutions
